Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

Published

Journal Article (Review)

The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions are made to incorporate advances related to tumor cell biology and diagnostic techniques as pertains to mycosis fungoides (MF) and Sézary syndrome (SS) since the 1979 publication of the original guidelines, to clarify certain variables that currently impede effective interinstitution and interinvestigator communication and/or the development of standardized clinical trials in MF and SS, and to provide a platform for tracking other variables of potential prognostic significance. Moreover, given the difference in prognosis and clinical characteristics of the non-MF/non-SS subtypes of cutaneous lymphoma, this revision pertains specifically to MF and SS. The evidence supporting the revisions is discussed as well as recommendations for evaluation and staging procedures based on these revisions.

Full Text

Duke Authors

Cited Authors

  • Olsen, E; Vonderheid, E; Pimpinelli, N; Willemze, R; Kim, Y; Knobler, R; Zackheim, H; Duvic, M; Estrach, T; Lamberg, S; Wood, G; Dummer, R; Ranki, A; Burg, G; Heald, P; Pittelkow, M; Bernengo, M-G; Sterry, W; Laroche, L; Trautinger, F; Whittaker, S; ISCL/EORTC,

Published Date

  • September 15, 2007

Published In

Volume / Issue

  • 110 / 6

Start / End Page

  • 1713 - 1722

PubMed ID

  • 17540844

Pubmed Central ID

  • 17540844

International Standard Serial Number (ISSN)

  • 0006-4971

Digital Object Identifier (DOI)

  • 10.1182/blood-2007-03-055749

Language

  • eng

Conference Location

  • United States